Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Test Availability
Veracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.
Read MorePosted by Andy Lundin | Nov 7, 2023 | Company News, Molecular Diagnostics |
Veracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.
Read MorePosted by Andy Lundin | Oct 10, 2023 | Cancer |
The genomic profiling test is approved to identify patients with solid tumors with RET gene fusions who may benefit from Retevmo treatment.
Read MorePosted by Chris Wolski | Sep 4, 2023 | POC Rapid Assays |
Hilab showcased its point-of-care Hemogram device capable of delivering a complete blood count with the assistance of artificial intelligence.
Read MorePosted by Andy Lundin | Jul 24, 2023 | Cancer, Flow Cytometry |
The technique uses two laser sources and detectors to mitigate noise and autofluorescence, and may help detect fluorescent tags.
Read MorePosted by Chris Wolski | May 19, 2023 | Disease States |
The accuracy of polygenic scores (PGSs) varies between individuals across a continuum of genetic ancestry.
Read More